Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Fate mapping reveals that microglia and recruited monocyte-derived macrophages are definitively distinguishable by phenotype in the retina

Open access
O’Koren, E. G., Mathew, R., Saban, D. R. · 2016 · Scientific Reports

Abstract

The recent paradigm shift that microglia are yolk sac-derived, not hematopoietic-derived, is reshaping our knowledge about the isolated role of microglia in CNS diseases, including degenerative conditions of the retina. However, unraveling microglial-specific functions has been hindered by phenotypic overlap of microglia with monocyte-derived macrophages. The latter are differentiated from recruited monocytes in neuroinflammation, including retina. Here we demonstrate the use of fate mapping wherein microglia and monocyte-derived cells are endogenously labeled with different fluorescent reporters. Combining this method with 12-color flow cytometry, we show that these two populations are definitively distinguishable by phenotype in retina. We prove that retinal microglia have a unique CD45 lo CD11c lo F4/80 lo I-A/I-E− signature, conserved in the steady state and during retinal injury. The latter was observed in the widely used light-induced retinal degeneration model and corroborated in other models, including whole-body irradiation/bone-marrow transplantation. The literature contains conflicting observations about whether microglia, including in the retina, increase expression of these markers in neuroinflammation. We show that monocyte-derived macrophages have elevated expression of these surface markers, not microglia. Our resolution of such phenotypic differences may serve as a robust way to help characterize isolated roles of these cells in retinal neuroinflammation and possibly elsewhere in CNS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep20636

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Phenotypic characterization of microglia in the normal retina of C57BL/6 mice. Intravenous anti-CD45 mAb method was used for flow cytometric exclusion of intravascular immune cells within retina29. Administration via IV route of CD45 mAb, i.e. IV-CD45 (BV711), was given to C57BL/6 mice 5 minutes before euthanasia, labeling intravascular immune cells of retina. Subsequently harvested retinas were ex vivo stained with the remaining conjugated mAbs, including APC-Cy7 conjugated anti-CD45. (a) Intravascular IV-CD45+ events correspond with CD45hi (APC-Cy7) cells, whereas extravascular IV-CD45− events correspond with CD45lo (APC-Cy7) cells of the retina. Cells were pre-gated on singlets. (b) IV-CD45+ cells contain circulating myeloid cells such as classical monocytes (Mo) and neutrophils (PMN), whereas IV-CD45− cells contain microglia. Cells were pre-gated on live singlets. (c) Evidence for a CD45lo CD11clo F4/80lo I-A/I-E− profile for retinal microglia. Extravascular IV-CD45− CD11b+ cells were compared to intravascular IV-CD45+ CD11b+ Mo and PMN, and examined for expression of the indicated markers. Flow cytometry plots are comprised of concatenated data from n = 4 retinas to increase the number of events for intravascular cell gating. Data is representative of at least 2 independent experiments, each with n = 4 individual retina samples.
Figure 1 Phenotypic characterization of microglia in the normal retina of C57BL/6 mice. Intravenous anti-CD45 mAb method was used for flow cytometric exclusion of intravascular immune cells within retina29. Administration via IV route of CD45 mAb, i.e. IV-CD45 (BV711), was given to C57BL/6 mice 5 minutes before euthanasia, labeling intravascular immune cells of retina. Subsequently harvested retinas were ex vivo stained with the remaining conjugated mAbs, including APC-Cy7 conjugated anti-CD45. (a) Intravascular IV-CD45+ events correspond with CD45hi (APC-Cy7) cells, whereas extravascular IV-CD45− events correspond with CD45lo (APC-Cy7) cells of the retina. Cells were pre-gated on singlets. (b) IV-CD45+ cells contain circulating myeloid cells such as classical monocytes (Mo) and neutrophils (PMN), whereas IV-CD45− cells contain microglia. Cells were pre-gated on live singlets. (c) Evidence for a CD45lo CD11clo F4/80lo I-A/I-E− profile for retinal microglia. Extravascular IV-CD45− CD11b+ cells were compared to intravascular IV-CD45+ CD11b+ Mo and PMN, and examined for expression of the indicated markers. Flow cytometry plots are comprised of concatenated data from n = 4 retinas to increase the number of events for intravascular cell gating. Data is representative of at least 2 independent experiments, each with n = 4 individual retina samples.CC BY · PubMed Central
Figure 2 Microglia and recruited mo-MFs are phenotypically distinguishable in the setting of whole-body irradiation and bone marrow transplantation (Rad/BMT). (a) Whole-body Rad/BMT leads to recruitment of myeloid cells into the retina. C57BL/6 mice were whole-body irradiated then grafted with GFP+ donor bone marrow (Rad/GFP-BMT). Using this method, we can firmly establish GFP+ cells as donor-derived whereas all GFP− cells (including microglia) are host-derived. After Rad/GFP-BMT, mice were rested for more than 3 months. Data is representative of 2 independent experiments. Cells were pre-gated on live CD45+ singlets. (b) Comprehensive phenotypic analysis reveals that microglia have a CD45lo CD11clo F4/80lo I-A/I-E− profile in the whole-body Rad/GFP-BMT setting. GFP− microglia were compared to extravascular GFP+ mo-MFs and intravascular classical Mo (IV Mo). (c) MFI indicates that the CD45lo CD11clo F4/80lo I-A/I-E− profile of GFP− microglia is significantly different from GFP+ mo-MFs. Data shown (mean ± s.d.) is a representative sample from n ≥ 4 individual samples/group. Significant differences were determined within samples by an unpaired t test (****p < 0.0001). Data is representative of 2 independent experiments.
Figure 2 Microglia and recruited mo-MFs are phenotypically distinguishable in the setting of whole-body irradiation and bone marrow transplantation (Rad/BMT). (a) Whole-body Rad/BMT leads to recruitment of myeloid cells into the retina. C57BL/6 mice were whole-body irradiated then grafted with GFP+ donor bone marrow (Rad/GFP-BMT). Using this method, we can firmly establish GFP+ cells as donor-derived whereas all GFP− cells (including microglia) are host-derived. After Rad/GFP-BMT, mice were rested for more than 3 months. Data is representative of 2 independent experiments. Cells were pre-gated on live CD45+ singlets. (b) Comprehensive phenotypic analysis reveals that microglia have a CD45lo CD11clo F4/80lo I-A/I-E− profile in the whole-body Rad/GFP-BMT setting. GFP− microglia were compared to extravascular GFP+ mo-MFs and intravascular classical Mo (IV Mo). (c) MFI indicates that the CD45lo CD11clo F4/80lo I-A/I-E− profile of GFP− microglia is significantly different from GFP+ mo-MFs. Data shown (mean ± s.d.) is a representative sample from n ≥ 4 individual samples/group. Significant differences were determined within samples by an unpaired t test (****p < 0.0001). Data is representative of 2 independent experiments.CC BY · PubMed Central
Figure 3 Microglia and recruited mo-MFs are phenotypically distinguishable in light injury, as revealed in shielded Rad/GFP-BMT hosts. (a) Head shielding protects host mice from radiation and radiation-induced Mo recruitment. C57BL/6 mice were irradiated with shielding then given donor GFP+ bone marrow. Retinas were analyzed 3 months later. Cells were pre-gated on live CD45+ singlets. (b) Light injury leads to myeloid cell recruitment in shielded Rad/GFP-BMT hosts. Three months after shielded Rad/GFP-BMT, mice were then subjected to light challenge (or not) and retinas were harvested 7 days later for analysis. Cells were pre-gated on live CD45+ singlets. (c,d) Comprehensive phenotypic analysis reveals that microglia have a CD45lo CD11clo F4/80lo I-A/I-E− profile during light injury, which is significantly different from recruited mo-MFs. GFP− microglia from retina of uninjured mice were compared to GFP+ mo-MFs and IV Mo from retinas of light-injured mice. Significant differences of data shown (mean ± s.d.) were determined across samples by an unpaired t test (****p < 0.0001). Light injury data is representative of n = 4 individual samples; pre-light injury data is comprised of n = 2 individual samples that are representative of 2 independent experiments.
Figure 3 Microglia and recruited mo-MFs are phenotypically distinguishable in light injury, as revealed in shielded Rad/GFP-BMT hosts. (a) Head shielding protects host mice from radiation and radiation-induced Mo recruitment. C57BL/6 mice were irradiated with shielding then given donor GFP+ bone marrow. Retinas were analyzed 3 months later. Cells were pre-gated on live CD45+ singlets. (b) Light injury leads to myeloid cell recruitment in shielded Rad/GFP-BMT hosts. Three months after shielded Rad/GFP-BMT, mice were then subjected to light challenge (or not) and retinas were harvested 7 days later for analysis. Cells were pre-gated on live CD45+ singlets. (c,d) Comprehensive phenotypic analysis reveals that microglia have a CD45lo CD11clo F4/80lo I-A/I-E− profile during light injury, which is significantly different from recruited mo-MFs. GFP− microglia from retina of uninjured mice were compared to GFP+ mo-MFs and IV Mo from retinas of light-injured mice. Significant differences of data shown (mean ± s.d.) were determined across samples by an unpaired t test (****p < 0.0001). Light injury data is representative of n = 4 individual samples; pre-light injury data is comprised of n = 2 individual samples that are representative of 2 independent experiments.CC BY · PubMed Central
Figure 4 Fate mapping with CX3CR1YFP−CreER/wt:R26RFP mice reveals that microglia and recruited mo-MFs are phenotypically distinguishable in light injury. (a) Fate mapping in CX3CR1YFP−CreER/wt:R26RFP mice differentially label microglia (i.e. YFP+ RFP+) vs. blood Mo (i.e. YFP+ RFP−), which is achieved by tamoxifen administration followed by a “wash out” period. Tissues were harvested 2 days after the last dose, or following a 60 day “wash out” period. Cells were pre-gated on live CD45+ CD11b+ Ly6G− singlets. (b) Fate mapping discerns microglia from recruited Mo-derived cells in light injured retinas. Following tamoxifen pulsing and subsequent “wash out” period, mice were subjected to light challenge (or not) and retinas were harvested 5 days later. (c,d) RFP+ microglia were compared to RFP− mo-MFs and IV Mo. Comprehensive phenotypic analysis reveals that microglia have a CD45lo CD11clo F4/80lo I-A/I-E− profile during light injury, which is significantly different from recruited mo-MFs. Data from uninjured and light-injured retina are representative of n = 2 and n = 5 individual samples, respectively. Data is representative of two independent experiments. Significant differences were determined within samples by an unpaired t test (****p < 0.0001). (e) Microglia and mo-MFs are distinguishable by surface staining of CD45, F4/80, or CD11c. Gated on extravascular CD11b+ retinal cells. Data shows different gating strategies using CD11b, CD45, and F4/80 to identify high and low expression cell populations. Subsequently, we analyzed RFP expression in each population to determine if the gating corresponds to genetic fate mapping. Cells were pre-gated on live CD45+ CD11b+ singlets. Data is representative of at least 2 independent experiments; each experiment has n = 4 individual samples.
Figure 4 Fate mapping with CX3CR1YFP−CreER/wt:R26RFP mice reveals that microglia and recruited mo-MFs are phenotypically distinguishable in light injury. (a) Fate mapping in CX3CR1YFP−CreER/wt:R26RFP mice differentially label microglia (i.e. YFP+ RFP+) vs. blood Mo (i.e. YFP+ RFP−), which is achieved by tamoxifen administration followed by a “wash out” period. Tissues were harvested 2 days after the last dose, or following a 60 day “wash out” period. Cells were pre-gated on live CD45+ CD11b+ Ly6G− singlets. (b) Fate mapping discerns microglia from recruited Mo-derived cells in light injured retinas. Following tamoxifen pulsing and subsequent “wash out” period, mice were subjected to light challenge (or not) and retinas were harvested 5 days later. (c,d) RFP+ microglia were compared to RFP− mo-MFs and IV Mo. Comprehensive phenotypic analysis reveals that microglia have a CD45lo CD11clo F4/80lo I-A/I-E− profile during light injury, which is significantly different from recruited mo-MFs. Data from uninjured and light-injured retina are representative of n = 2 and n = 5 individual samples, respectively. Data is representative of two independent experiments. Significant differences were determined within samples by an unpaired t test (****p < 0.0001). (e) Microglia and mo-MFs are distinguishable by surface staining of CD45, F4/80, or CD11c. Gated on extravascular CD11b+ retinal cells. Data shows different gating strategies using CD11b, CD45, and F4/80 to identify high and low expression cell populations. Subsequently, we analyzed RFP expression in each population to determine if the gating corresponds to genetic fate mapping. Cells were pre-gated on live CD45+ CD11b+ singlets. Data is representative of at least 2 independent experiments; each experiment has n = 4 individual samples.CC BY · PubMed Central
Figure 5 Fate mapping with CX3CR1YFP−CreER/wt:R26RFP mice using confocal analysis. Following tamoxifen pulsing and a “wash out” period, mice were subjected to light challenge (or not) and retinas were harvested 5 days later. (a) Uninjured retinas contain microglia (inset: YFP+ RFP+) and display normal retinal architecture, as visualized by DAPI (outer nuclear layer = ONL; inner nuclear layer = INL; ganglion cell layer = GCL). (b) Light injured retinas have a thin ONL and possess microglia and recruited mo-MFs (inset: YFP+ RFP+ and YFP+ RFP−, respectively). Asterisks indicate microglia; arrowheads indicate recruited mo-MFs. Data is representative of two independent experiments; each experiment contained data from individual samples, uninjured n = 2 and injured n = 5.
Figure 5 Fate mapping with CX3CR1YFP−CreER/wt:R26RFP mice using confocal analysis. Following tamoxifen pulsing and a “wash out” period, mice were subjected to light challenge (or not) and retinas were harvested 5 days later. (a) Uninjured retinas contain microglia (inset: YFP+ RFP+) and display normal retinal architecture, as visualized by DAPI (outer nuclear layer = ONL; inner nuclear layer = INL; ganglion cell layer = GCL). (b) Light injured retinas have a thin ONL and possess microglia and recruited mo-MFs (inset: YFP+ RFP+ and YFP+ RFP−, respectively). Asterisks indicate microglia; arrowheads indicate recruited mo-MFs. Data is representative of two independent experiments; each experiment contained data from individual samples, uninjured n = 2 and injured n = 5.CC BY · PubMed Central
Figure 6 Analysis of extravascular I-A/I-Ehi myeloid cells in normal retina. (a) Identification of I-A/I-Ehi myeloid cells in the retina. Cells were pre-gated on live CD45+ singlets. (b) I-A/I-Ehi cells in the normal retina are putative MFs, as indicated by positive CD64 and F4/80 expression. Data is representative of two independent experiments; each experiment has n = 4 individual samples. (c) Evaluation of I-A/I-Ehi putative MFs, regarding long-lived and radio-resistant status. Mice were subjected to whole-body or shielded Rad/GFP-BMT then retinas were harvested 3 months later. I-A/I-Ehi putative MFs were evident following shielded, but not whole-body, Rad/GFP-BMT. Cells were pre-gated on live CD45+ singlets. Data is representative of 2 independent experiments; each plot is representative of 2 to 4 individual samples. (d) Fate mapping in CX3CR1YFP−CreER/wt:R26RFP mice to further evaluate possible long-lived status of I-A/I-Ehi putative MFs. Mice were tamoxifen pulsed. Then after 3 months, mice were subjected to light challenge (or not) and retinas were harvested 5 days later for flow cytometry analyses. Long-lived RFP+ cells were analyzed for the presence/absence of I-A/I-Ehi putative MFs. Cells were pre-gated on live CD45+ CD11b+ singlets. Data is representative of two independent experiments; each experiment contained data from individual samples, uninjured n = 2 and injured n = 5.
Figure 6 Analysis of extravascular I-A/I-Ehi myeloid cells in normal retina. (a) Identification of I-A/I-Ehi myeloid cells in the retina. Cells were pre-gated on live CD45+ singlets. (b) I-A/I-Ehi cells in the normal retina are putative MFs, as indicated by positive CD64 and F4/80 expression. Data is representative of two independent experiments; each experiment has n = 4 individual samples. (c) Evaluation of I-A/I-Ehi putative MFs, regarding long-lived and radio-resistant status. Mice were subjected to whole-body or shielded Rad/GFP-BMT then retinas were harvested 3 months later. I-A/I-Ehi putative MFs were evident following shielded, but not whole-body, Rad/GFP-BMT. Cells were pre-gated on live CD45+ singlets. Data is representative of 2 independent experiments; each plot is representative of 2 to 4 individual samples. (d) Fate mapping in CX3CR1YFP−CreER/wt:R26RFP mice to further evaluate possible long-lived status of I-A/I-Ehi putative MFs. Mice were tamoxifen pulsed. Then after 3 months, mice were subjected to light challenge (or not) and retinas were harvested 5 days later for flow cytometry analyses. Long-lived RFP+ cells were analyzed for the presence/absence of I-A/I-Ehi putative MFs. Cells were pre-gated on live CD45+ CD11b+ singlets. Data is representative of two independent experiments; each experiment contained data from individual samples, uninjured n = 2 and injured n = 5.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Cited by

See all 220

Metadata

Authors
O’Koren, E. G., Mathew, R., & Saban, D. R.
Affiliations
Duke University (US)
Corresponding author
Saban, D. R.
Venue
Scientific Reports
Published
2016-02-09
Volume
6
Issue
1
Pages
20636-20636
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2265779583
Cited by
220
References
57
Citations by year
2026: 7 · 2025: 25 · 2024: 28 · 2023: 25 · 2022: 18 · 2021: 24 · 2020: 23 · 2019: 20 · 2018: 23 · 2017: 18 · 2016: 9
FWCI
12.78
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Research to Prevent Blindness (R01EY021798)
  • National Eye Institute (P30EY005722, R01EY021798)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
retinal microglia, monocyte-derived macrophages, fate mapping, microglial origin, retinal neuroinflammation, retinal degeneration, light-induced retinal degeneration, CD45, CD11c, F4/80, bone marrow transplantation, retinal damage
MeSH terms
Animals, Flow Cytometry, Macrophages, Mice, Transgenic, Monocytes, Retina, Microglia, Mice, Cell Tracking

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fate mapping reveals that microglia and recruited monocyte-derived macrophages are definitively distinguishable by phenotype in the retina. https://app.cochat.ai/papers/10.1038/srep20636
The paper
O’Koren, E. G., Mathew, R., & Saban, D. R. (2016). Fate mapping reveals that microglia and recruited monocyte-derived macrophages are definitively distinguishable by phenotype in the retina. Scientific Reports. https://doi.org/10.1038/srep20636

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.